CI

At a glance

ClinicalIndex Comparison Record
Early Ph 1Completed· 54 enrolled
Drug / intervention
Ginger Extract +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03705832
NCT03705832Early Ph 1Completed
CompareCT.gov

Ginger's Therapeutic Potential in Asthma

Emily DiMango, MD·interventional·Posted Oct 15, 2018·Updated Mar 27, 2023

In Brief

A Early Phase 1 clinical trial evaluating Ginger Extract and Placebo for Asthma. Completed, enrolled 54 participants across 1 site.

Detailed Summary

This is a randomized, double blind, placebo controlled study to study whether there are potential benefits of consuming ginger by individuals with asthma.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAsthma
CountriesUnited States
CollaboratorsNational Center for Complementary and Integrative Health (NCCIH)

Timeline

Early Ph 1CompletedFinished
20192020202120222023202420252026
First PostedOct 15, 2018
Enrollment StartAug 22, 2019
Primary CompletionFeb 28, 2021
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 7.7 years ago

Interventions

Ginger Extractdrug

2gm Capsule of Ginger extract

Placebodrug

Matching Placebo